Trials / Sponsors / Epidemiological and Clinical Research Information Network
Epidemiological and Clinical Research Information Network
Academic / Other · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | A Phase III Study of 2nd-line XELIRI ± Bevacizumab vs. FOLFIRI ± Bevacizumab in mCRC Colorectal Neoplasms, Neoplasm Metastasis, Intestinal Neoplasms | Phase 3 | 2013-12-02 |
| Unknown | XParTS II: Capecitabine/CDDP(XP) and S-1/CDDP(SP) as the First-line Treatment for Advanced Gastric Cancer Gastric Cancer | Phase 2 | 2011-08-01 |
| Unknown | XParTS: Capecitabine/Cisplatin(XP) for Recurrent Gastric Cancer Gastric Cancer | Phase 2 | 2011-07-01 |